Shopping Cart
- Remove All
Your shopping cart is currently empty
WNK1-IN-1 is a selective WNK1 (With No lysine (K) 1) inhibitor (IC50 = 1.6 μM) that inhibits the phosphorylation of the endogenous substrate OSR1, and can be used to study hypertension and cancer.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $68 | In Stock | |
| 5 mg | $163 | In Stock | |
| 10 mg | $263 | In Stock | |
| 25 mg | $538 | In Stock | |
| 50 mg | $868 | In Stock | |
| 100 mg | $1,450 | In Stock | |
| 1 mL x 10 mM (in DMSO) | $179 | In Stock |
| Description | WNK1-IN-1 is a selective WNK1 (With No lysine (K) 1) inhibitor (IC50 = 1.6 μM) that inhibits the phosphorylation of the endogenous substrate OSR1, and can be used to study hypertension and cancer. |
| In vitro | WNK1-IN-1 (0.2-12.5 μM, 24 hours) treats endogenous OSR1 phosphorylated MDAMB231 breast cancer cells with an IC50 value of 4.3 μM. [1] |
| Synonyms | WNK1-IN1 |
| Molecular Weight | 446.14 |
| Formula | C13H15BrCl2N2O4S |
| Cas No. | 324022-39-1 |
| Smiles | [O-][N+](C1=CC(S(=O)(C(Br)(Cl)Cl)=O)=CC=C1NC2CCCCC2)=O |
| Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 80 mg/mL (179.32 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.